Register Login

CRISPR Therapeutics (CRSP)

  • Event
  • June 13, 2022, 12:02 UTC

(19% Negative) CRISPR THERAPEUTICS AG (CRSP) Announces Delay in reductions Trials for transfusion volume Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 6:57 a.m.

    📋 CRISPR THERAPEUTICS AG (CRSP) - Clinical Trial Update

    Filing Date: 2022-06-13

    Accepted: 2022-06-13 08:02:42

    Event Type: Clinical Trial Update

    Event Details:

    CRISPR Therapeutics (CRSP) Announces Clinical Trial Update CRISPR Therapeutics (CRSP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: reductions
    • Diseases/Conditions: transfusion volume
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: SCD

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CRISPR Therapeutics
    • CIK: 0001674416
    • Ticker Symbol: CRSP
    • Period End Date: 2022-06-11
    • Document Type: 8-K

Search

News categories